Clinical Trials
99
Trial Phases
5 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (99 trials with phase data)• Click on a phase to view related trials
Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
- Conditions
- Asthma
- Interventions
- First Posted Date
- 2016-01-07
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 1430
- Registration Number
- NCT02649478
- Locations
- 🇺🇸
Roxane Laboratories Research Site #30, Glendale, Arizona, United States
🇺🇸Roxane Laboratories Research Site #46, Phoenix, Arizona, United States
🇺🇸Roxane Laboratories Research Site #1, Surprise, Arizona, United States
Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fasted Conditions
- First Posted Date
- 2013-07-19
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 26
- Registration Number
- NCT01903122
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Las Vegas, Nevada, United States
Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fed Conditions
- First Posted Date
- 2013-07-19
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 27
- Registration Number
- NCT01903109
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Las Vegas, Nevada, United States
Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions
- First Posted Date
- 2012-10-23
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 34
- Registration Number
- NCT01712100
- Locations
- 🇺🇸
Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research), San Antonio, Texas, United States
Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions
- Conditions
- Hypertension
- Interventions
- First Posted Date
- 2012-10-23
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Roxane Laboratories
- Target Recruit Count
- 37
- Registration Number
- NCT01712139
- Locations
- 🇺🇸
Worldwide Clinical Trials Drug Development Solutions (formerly CEDRA Clinical Research), San Antonio, Texas, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 20
- Next